# GSTA5

## Overview
GSTA5 is a gene that encodes the enzyme glutathione S-transferase alpha 5, a member of the glutathione S-transferase (GST) family, which is involved in the detoxification of endogenous and exogenous compounds. The enzyme plays a pivotal role in cellular defense mechanisms by catalyzing the conjugation of reduced glutathione to electrophilic substrates, thereby facilitating their neutralization and excretion. This process is crucial for the metabolism of xenobiotics and protection against oxidative stress, particularly in the liver where GSTA5 is predominantly active (Nebert2004Analysis; Sherratt2001Glutathione). Beyond its detoxification functions, GSTA5 is implicated in modulating signal transduction pathways and receptor functions, suggesting a broader involvement in cellular processes (Sherratt2001Glutathione). Alterations in GSTA5 expression have been linked to drug resistance in cancer therapy and adaptive responses to drug-induced toxicity, highlighting its clinical significance (Kazi2002Expression; Myers2010Repeated).

## Function
GSTA5, a member of the glutathione S-transferase (GST) family, plays a crucial role in detoxification processes within human cells. This enzyme catalyzes the conjugation of reduced glutathione (GSH) to a variety of electrophilic compounds, facilitating their neutralization and subsequent excretion from the body. This activity is essential for the metabolism of xenobiotics and protection against oxidative stress, contributing to cellular homeostasis and defense mechanisms against toxic compounds (Nebert2004Analysis; Sherratt2001Glutathione).

GSTA5 is primarily active in the liver, where it aids in maintaining metabolic balance and protecting cellular components from damage. The enzyme's activity involves the formation of a thioether bond between GSH and electrophilic substrates, which helps in detoxifying potentially harmful compounds, such as carcinogens and products of oxidative stress (Sherratt2001Glutathione).

In addition to its detoxification role, GSTA5 is involved in modulating signal transduction pathways and influencing receptor functions, indicating a broader role in cellular processes beyond detoxification. This includes interactions with kinases and other proteins, which can affect stress responses and cellular resistance to oxidative damage (Sherratt2001Glutathione).

## Clinical Significance
Alterations in the expression of the GSTA5 gene have been associated with increased resistance to certain toxic agents, which may have implications for cancer treatment and resistance. The expression of GSTA5 in cell lines has been shown to provide increased resistance to alkylating agents such as chlorambucil and melphalan, which are commonly used in chemotherapy. This suggests that overexpression of GSTA5 could contribute to tumor resistance against these treatments, potentially impacting the effectiveness of chemotherapy in cancer patients (Kazi2002Expression).

GSTA5 also plays a role in detoxifying toxic aldehydes, such as acrolein and crotonaldehyde, which are products of lipid peroxidation and environmental pollutants. Its ability to conjugate these aldehydes with glutathione reduces their cytotoxicity, indicating that alterations in GSTA5 expression could affect cellular defense mechanisms against oxidative stress and environmental toxins (Kazi2002Expression).

In the context of drug metabolism, repeated administration of oxycodone has been shown to significantly upregulate GSTA5 expression in the liver, suggesting a potential adaptive response to drug-induced toxicity. This upregulation may influence the metabolism and detoxification of drugs, potentially affecting drug interactions and efficacy (Myers2010Repeated).


## References


[1. (Nebert2004Analysis) Daniel W Nebert and Vasilis Vasiliou. Analysis of the glutathione s-transferase (gst) gene family. Human Genomics, 1(6):460, 2004. URL: http://dx.doi.org/10.1186/1479-7364-1-6-460, doi:10.1186/1479-7364-1-6-460. This article has 271 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1479-7364-1-6-460)

[2. (Myers2010Repeated) Alan L Myers, Hazem E Hassan, Insong J Lee, and Natalie D Eddington. Repeated administration of oxycodone modifies the gene expression of several drug metabolising enzymes in the hepatic tissue of male sprague-dawley rats, including glutathione s-transferase a-5 (rgsta5) and cyp3a2†. Journal of Pharmacy and Pharmacology, 62(2):189–196, February 2010. URL: http://dx.doi.org/10.1211/jpp.62.02.0006, doi:10.1211/jpp.62.02.0006. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1211/jpp.62.02.0006)

[3. (Sherratt2001Glutathione) Philip J. Sherratt and John D. Hayes. Glutathione s‐transferases. November 2001. URL: http://dx.doi.org/10.1002/0470846305.ch9, doi:10.1002/0470846305.ch9. This article has 57 citations.](https://doi.org/10.1002/0470846305.ch9)

[4. (Kazi2002Expression) Shubana Kazi and Elizabeth M Ellis. Expression of rat liver glutathione-s-transferase gsta5 in cell lines provides increased resistance to alkylating agents and toxic aldehydes. Chemico-Biological Interactions, 140(2):121–135, May 2002. URL: http://dx.doi.org/10.1016/s0009-2797(02)00023-6, doi:10.1016/s0009-2797(02)00023-6. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0009-2797(02)00023-6)